Quay Pharma appoints scientific manager

Mark Powell takes on wider technical responsibility

As part of its continuing expansion programme, Quay Pharma, based in Deeside, UK, has appointed Mark Powell as scientific manager. Powell has been with Quay for nearly eight years and was previously in charge of the company’s Analytical Development Group. He has also been elected Honorary Treasurer for the Analytical Division of the Royal Society of Chemistry (RSC).

Dr Mark Powell

In his new role, Powell will take on wider technical responsibility and seek to raise further the scientific profile of the company. Quay’s areas of expertise in solid dosage development cover a range of formulation types including lipophilic systems, and are supported by the development of analytical methods for the recovery of API from lipid systems.

As Honorary Treasurer of the RSC Analytical Division, Powell will oversee the Analytical Chemistry Trust Fund, which helps to support research projects, provides travel grants for overseas students and promotes an annual schools competition. The fund is also now introducing a world scholarship programme, helping researchers in developing countries to spend time and gain experience in the UK.

Companies